Phase Holographic Imaging PHI AB (XSAT:PHI) ROCE %: -78.58% (As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:PHI Phase Holographic Imaging PHI AB XSAT:PHI
47 GF Score
Price kr0.53
GF Value kr2.80
! 5 Warning Signs
View Full Analysis

What is Phase Holographic Imaging PHI AB ROCE %?

Phase Holographic Imaging PHI AB XSAT:PHI 47 ROCE % is -78.58% as of Oct. 2025. GuruFocus rates XSAT:PHI with a GF Score™ of 47/100 and a GF Value™ of kr2.80. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Phase Holographic Imaging PHI AB's annualized ROCE % for the quarter that ended in Oct. 2025 was -78.58%.

Phase Holographic Imaging PHI AB  (XSAT:PHI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Phase Holographic Imaging PHI AB ROCE % Related Terms

Phase Holographic Imaging PHI AB ROCE % Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB ROCE % Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -108.47 -62.74 -54.45 -69.27 -39.63

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.44 -15.40 -40.75 -77.18 -78.58
XSAT:PHI
47GF Score
Phase Holographic Imaging PHI AB XSAT:PHI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phase Holographic Imaging PHI AB ROCE % Calculation

Phase Holographic Imaging PHI AB's annualized ROCE % for the fiscal year that ended in Apr. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Apr. 2025 )  (A: Apr. 2024 )(A: Apr. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Apr. 2025 )  (A: Apr. 2024 )(A: Apr. 2025 )
=-14.909/( ( (33.002 - 8.435) + (55.853 - 5.183) )/ 2 )
=-14.909/( (24.567+50.67)/ 2 )
=-14.909/37.6185
=-39.63 %

Phase Holographic Imaging PHI AB's ROCE % of for the quarter that ended in Oct. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Oct. 2025 )  (Q: Jul. 2025 )(Q: Oct. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Oct. 2025 )  (Q: Jul. 2025 )(Q: Oct. 2025 )
=-28.588/( ( (44.8 - 4.768) + (36.913 - 4.188) )/ 2 )
=-28.588/( ( 40.032 + 32.725 )/ 2 )
=-28.588/36.3785
=-78.58 %

(1) Note: The EBIT data used here is four times the quarterly (Oct. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -78.58% mean?
Phase Holographic Imaging PHI AB (XSAT:PHI) has a ROCE % of -78.58% as of Oct. 2025.
Is Phase Holographic Imaging PHI AB's ROCE % too high?
Phase Holographic Imaging PHI AB's current ROCE % is -78.58%. Overall, Phase Holographic Imaging PHI AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Phase Holographic Imaging PHI AB's ROCE % compare to ABT and BSX?
Phase Holographic Imaging PHI AB's ROCE % of -78.58% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.22, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current ROCE % is -78.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (XSAT:PHI) has a current ROCE % of -78.58%. The stock's GF Value™ is kr2.80, compared to a current price of kr0.53 — trading 81.1% below its estimated fair value. The current ROCE % is -78.58%. Phase Holographic Imaging PHI AB's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (XSAT:PHI), the current ROCE % is -78.58% as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phase Holographic Imaging PHI AB (XSAT:PHI) Overvalued in 2026?

Based on GuruFocus' analysis, Phase Holographic Imaging PHI AB stock appears to be undervalued. The current stock price of kr0.53 is trading 81.1% below its estimated GF Value™ of kr2.80.

Key valuation signals for XSAT:PHI:

  • ROCE %: -78.58%
  • GF Value™: kr2.80 vs. price of kr0.53 (81.1% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the XSAT:PHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
47GF Score

Get the complete analysis for XSAT:PHI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.53
Price
kr2.80
GF Value